NAFDAC Issues Alert on Falsified Betaclox Antibiotic in Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert (No. 37 of 2025) regarding the discovery of falsified Betaclox antibiotics in Nigeria. The product, initially procured in Gamboru Market, Maiduguri, was found to contain fraudulent registration details and belong to a different medicine, Mebendazole 500mg, manufactured by Chi Ltd.
NAFDAC highlighted concerns over the misappropriation of registration numbers and the possibility of unauthorized use of the Betaclox name. Health professionals and the public are urged to report any suspicious sale of substandard or falsified medicines to NAFDAC.
Plus234Feed summary based on reporting from Legit NG. Read the original report below.
Read full article
Continue on Legit NG
Get the week in one email
Top stories, NPFL results, the naira — every Friday morning. Free, one email a week.
Related Stories
NAFDAC Issues Urgent Warning Over Fake Betaclox Antibiotic in Nigeria
NAFDAC Recalls Substandard Antibiotics Over Safety Concerns
NAFDAC Warns of Substandard Edible Oils in Nigeria, Urges Vigilance
NAFDAC Recalls Substandard Drugs Over Health Risks
NAFDAC Withdraws Approvals for 101 Products in Nigeria
NAFDAC Destroys ₦5bn Fake Products in Nasarawa to Protect Consumers
Get Plus234Feed on messaging apps
Same headlines, delivered where you already scroll.
